Physician

Srinath Sundararajan, MD

According to 2025 Medicare claims, Srinath Sundararajan, MD (NPI: 1316176597) practices hematology/oncology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Harris, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1821265265; TIN: 752131429) and primary practice location at 77493-2711. Sundararajan is affiliated with the Baylor Scott & White Quality Alliance (ACO ID: A2542) and Main Street Rural Health Hickory ACO LLC (ACO ID: A5334), participating under the MSSP model.

Sundararajan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 364 traditional Medicare patients, billed 130,743 HCPCS/CPT codes, and received $2,377,326 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,228 prescription claims across 185 beneficiaries totaling $1,929,148 in drug costs, led by Cabometyx (Cabozantinib S-Malate). 2022 DME data shows 15 claims. Open Payments data shows 37 records totaling $1,239. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $5,542 to $2,377,326. Similarly, Part D prescription costs have risen steadily, from $30,997 to $1,929,148. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.